GeekWire

JULY 7, 2021

Icosavax creates virus-like particles with technology licensed from the University of Washington’s Institute for Protein Design. Securities and Exchange Commission. Proteomics company Nautilus Biotechnology went public via a SPAC last month and Absci, developing a drug discovery platform, filed to go public just last week.

Development 142

Development Biotechnology Pharmaceuticals .Net 142

GeekWire

MARCH 9, 2023

The publicly traded Seattle biotech company hired investment bank SVB Securities to review potential alternatives including a sale, merger, asset divestiture or licensing. “It Last week Novo Nordisk announced it was laying off 86 workers and shutting a lab site in Seattle.

Biotechnology 114

Biotechnology Licensing Programming Banking 114

GeekWire

SEPTEMBER 18, 2021

Washington State University assistant professor and Appiture Biotechnologies co-founder Georgina Lynch. Medcurity makes it easier for healthcare organizations to comply with federal privacy and security laws through an online series of queries resembling Turbotax. WSU Photo).

Biotechnology 135

Biotechnology Quality Assurance Research Meeting 135

GeekWire

MARCH 18, 2022

Propel Bio is seeking to raise a pooled investment fund of $150 million, according to a filing Friday morning with the Securities and Exchange Commission. Kawas co-founded Athira (originally M3 Biotechnology) in 2011. Papers with altered images were cited in an earlier patent licensed by the company from WSU.

Company 99

Company Biotechnology Research Journal 99

GeekWire

FEBRUARY 7, 2022

Founded in 2010, Leafly’s online marketplace lets customers shop and select cannabis products from licensed retailers. Leafly is among a group of Seattle-area companies going public via the SPAC route, joining a list that includes Rover, Nautilus Biotechnology, and Getty Images. Shares were up about 7% as of Monday afternoon.

Company 100

Company Retail Industry Licensing 100